https://sputnikglobe.com/20200910/russia-wants-to-make-its-vaccine-against-covid-19-available-in-every-country-rdif-ceo-says-1080423126.html
Russia Wants to Make Its Vaccine Against COVID-19 Available in Every Country, RDIF CEO Says
Russia Wants to Make Its Vaccine Against COVID-19 Available in Every Country, RDIF CEO Says
MOSCOW (Sputnik) - Russia wants to provide the Sputnik V vaccine to all countries without discriminating against anyone, Kirill Dmitriev, the chief executive... 10.09.2020, Sputnik International
2020-09-10T20:07+0000
2020-09-10T20:07+0000
2020-09-10T20:46+0000
/html/head/meta[@name='og:title']/@content
/html/head/meta[@name='og:description']/@content
https://cdn1.img.sputnikglobe.com/img/07e4/08/1a/1080284166_0:86:3073:1814_1920x0_80_0_0_82f46cd60bfe4e2ecc9732e99334752f.jpg
russia
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
2020
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
newsfeed, russia, russian direct investment fund (rdif), coronavirus
newsfeed, russia, russian direct investment fund (rdif), coronavirus
Russia Wants to Make Its Vaccine Against COVID-19 Available in Every Country, RDIF CEO Says
20:07 GMT 10.09.2020 (Updated: 20:46 GMT 10.09.2020) MOSCOW (Sputnik) - Russia wants to provide the Sputnik V vaccine to all countries without discriminating against anyone, Kirill Dmitriev, the chief executive officer of the Russian Direct Investment Fund (RDIF), involved in the development of the vaccine, said on Thursday.
"Only in partnership with other countries can we manufacture our vaccine and we want to make it available in every single country, without any discrimination," Dmitriev said.
He emphasized Russia's willingness to cooperate with international partners.
"Russia has a very open position, a position partnership and readiness to cooperate with all international companies. We are doing solid negotiation with GAVI and CEPI, as well as the WHO and all the leading international organizations that manufacture vaccines and are involved in their research and development," Dmitriev said.
The Russian company has earlier noted that the Russian vaccine clinical trials results showed human adenoviral vectors may be better option than vaccines using mRNK or chimpanzee adenovirus.
Dmitriev argued that the western media were silent on the dangers of using experimental approaches to vaccine development such as those based on the chimpanzee adenovirus.
"When we talk about that to the western media, we do see that the difference about the human and chimpanzee adenovirus is being blocked by the western media," Dmitriev mentioned.
Sputnik V was registered by the Russian Health Ministry on 11 August, becoming the first registered vaccine against COVID-19 in the world.
